These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 17077279)

  • 21. Phorbol ester potentiates the growth inhibitory effects of troglitazone via up-regulation of PPARgamma in A549 cells.
    Kim HJ; Woo IS; Kang ES; Eun SY; Kim GH; Ham SA; Kim HJ; Lee JH; Chang KC; Kim JH; Lee HT; Seo HG
    Biochem Biophys Res Commun; 2006 Oct; 349(2):660-7. PubMed ID: 16945329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression during liver regeneration after partial hepatectomy in mice lacking type 1 tumor necrosis factor receptor.
    Shimizu T; Togo S; Kumamoto T; Makino H; Morita T; Tanaka K; Kubota T; Ichikawa Y; Nagasima Y; Okazaki Y; Hayashizaki Y; Shimada H
    J Surg Res; 2009 Apr; 152(2):178-88. PubMed ID: 18639250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mice lacking bi-1 gene show accelerated liver regeneration.
    Bailly-Maitre B; Bard-Chapeau E; Luciano F; Droin N; Bruey JM; Faustin B; Kress C; Zapata JM; Reed JC
    Cancer Res; 2007 Feb; 67(4):1442-50. PubMed ID: 17308082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma.
    Cuzzocrea S; Mazzon E; Dugo L; Patel NS; Serraino I; Di Paola R; Genovese T; Britti D; De Maio M; Caputi AP; Thiemermann C
    Arthritis Rheum; 2003 Dec; 48(12):3544-56. PubMed ID: 14674008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rosiglitazone regulates c-reactive protein-induced inflammatory responses via glucocorticoid receptor-mediated inhibition of p38 mitogen-activated protein kinase-toll-like receptor 4 signal pathway in vascular smooth muscle cells.
    Liu N; Liu JT; Ji YY; Lu PP
    J Cardiovasc Pharmacol; 2011 Mar; 57(3):348-56. PubMed ID: 21383592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells.
    Wu Y; Zhao XD; Zhuang Z; Xue YJ; Cheng HL; Yin HX; Shi JX
    Brain Res; 2010 Mar; 1322():102-8. PubMed ID: 20132800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PPARgamma ligands suppress the feedback loop between E2F2 and cyclin-E1.
    Komatsu Y; Ito I; Wayama M; Fujimura A; Akaogi K; Machida H; Nakajima Y; Kuroda T; Ohmori K; Murayama A; Kimura K; Yanagisawa J
    Biochem Biophys Res Commun; 2008 May; 370(1):145-8. PubMed ID: 18355447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of peroxisome proliferator-activated receptor-gamma in hepatic ischemia/reperfusion injury in mice.
    Akahori T; Sho M; Hamada K; Suzaki Y; Kuzumoto Y; Nomi T; Nakamura S; Enomoto K; Kanehiro H; Nakajima Y
    J Hepatol; 2007 Dec; 47(6):784-92. PubMed ID: 17936399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postponing the Hypoglycemic Response to Partial Hepatectomy Delays Mouse Liver Regeneration.
    Huang J; Schriefer AE; Cliften PF; Dietzen D; Kulkarni S; Sing S; Monga SP; Rudnick DA
    Am J Pathol; 2016 Mar; 186(3):587-99. PubMed ID: 26772417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PAM-1616, a selective peroxisome proliferator-activated receptor γ modulator with preserved anti-diabetic efficacy and reduced adverse effects.
    Kim MK; Chae YN; Choi SH; Moon HS; Son MH; Bae MH; Choi HH; Hur Y; Kim E; Park YH; Park CS; Kim JG; Lim JI; Shin CY
    Eur J Pharmacol; 2011 Jan; 650(2-3):673-81. PubMed ID: 20974124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skp2 promotes adipocyte differentiation via a p27Kip1-independent mechanism in primary mouse embryonic fibroblasts.
    Okada M; Sakai T; Nakamura T; Tamamori-Adachi M; Kitajima S; Matsuki Y; Watanabe E; Hiramatsu R; Sakaue H; Kasuga M
    Biochem Biophys Res Commun; 2009 Feb; 379(2):249-54. PubMed ID: 19109928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.
    Berthiaume M; Laplante M; Tchernof A; Deshaies Y
    Int J Obes (Lond); 2007 Nov; 31(11):1660-70. PubMed ID: 17579631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PAR-1622 is a selective peroxisome proliferator-activated receptor gamma partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention.
    Kim MK; Chae YN; Kim HS; Choi SH; Son MH; Kim SH; Kim JK; Moon HS; Park SK; Shin YA; Kim JG; Lee CH; Lim JI; Shin CY
    Arch Pharm Res; 2009 May; 32(5):721-7. PubMed ID: 19471887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome Proliferator-Activated Receptor gamma negatively regulates liver regeneration after partial hepatectomy via the HGF/c-Met/ERK1/2 pathways.
    Cheng Z; Liu L; Zhang XJ; Lu M; Wang Y; Assfalg V; Laschinger M; von Figura G; Sunami Y; Michalski CW; Kleeff J; Friess H; Hartmann D; Hüser N
    Sci Rep; 2018 Aug; 8(1):11894. PubMed ID: 30089804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired liver regeneration by β-glucosylceramide is associated with decreased fat accumulation.
    Ben Ya'acov A; Lalazar G; Zolotaryova L; Steinhardt Y; Lichtentein Y; Ilan Y; Shteyer E
    J Dig Dis; 2013 Aug; 14(8):425-32. PubMed ID: 23575221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PPARγ alleviated hepatocyte steatosis through reducing SOCS3 by inhibiting JAK2/STAT3 pathway.
    Bi J; Sun K; Wu H; Chen X; Tang H; Mao J
    Biochem Biophys Res Commun; 2018 Apr; 498(4):1037-1044. PubMed ID: 29550470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver Regeneration Is Impaired in Mice with Acute Exposure to a Very Low Carbohydrate Diet.
    Chen H; Lin Y; Sun W; Cai Y; Li H
    Dig Dis Sci; 2017 May; 62(5):1256-1264. PubMed ID: 28265828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p21 is required for dextrose-mediated inhibition of mouse liver regeneration.
    Weymann A; Hartman E; Gazit V; Wang C; Glauber M; Turmelle Y; Rudnick DA
    Hepatology; 2009 Jul; 50(1):207-15. PubMed ID: 19441104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of STAT3 in liver regeneration.
    Terui K; Ozaki M
    Drugs Today (Barc); 2005 Jul; 41(7):461-9. PubMed ID: 16193099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional Relationships between Lipid Metabolism and Liver Regeneration.
    Rudnick DA; Davidson NO
    Int J Hepatol; 2012; 2012():549241. PubMed ID: 22319652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.